U.S. Capital Wealth Advisors, LLC Abb Vie Inc. Transaction History

U.S. Capital Wealth Advisors, LLC

$2.65 Billion
Q3 2024

A detailed history of U.S. Capital Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, U.S. Capital Wealth Advisors, LLC holds 127,798 shares of ABBV stock, worth $22.5 Million. This represents 0.95% of its overall portfolio holdings.

Number of Shares

127,798

Previous 128,701 0.7%

Holding current value

$22.5 Million

Previous $22.1 Million 14.33%

% of portfolio

0.95%

Previous 0.9%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$163.84 - $199.33 $147,947 - $179,994	-903 Reduced 0.7%	127,798 $25.2 Million
Q2 2024 Jul 11, 2024	SELL	$154.79 - $180.76 $136,679 - $159,611	-883 Reduced 0.68%	128,701 $22.1 Million
Q1 2024 May 10, 2024	SELL	$159.82 - $182.1 $2.92 Million - $3.32 Million	-18,249 Reduced 12.34%	129,584 $23.6 Million
Q4 2023 Feb 06, 2024	SELL	$137.6 - $154.97 $6.2 Million - $6.98 Million	-45,031 Reduced 23.35%	147,833 $22.9 Million
Q3 2023 Oct 19, 2023	SELL	$133.59 - $154.65 $587,662 - $680,305	-4,399 Reduced 2.23%	192,864 $28.7 Million
Q2 2023 Aug 04, 2023	SELL	$132.51 - $164.9 $1.53 Million - $1.9 Million	-11,524 Reduced 5.52%	197,263 $26.6 Million
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $801,284 - $922,798	5,541 Added 2.73%	208,787 $33.3 Million
Q4 2022 Feb 03, 2023	SELL	$138.31 - $165.87 $2.92 Million - $3.5 Million	-21,116 Reduced 9.41%	203,246 $32.9 Million
Q3 2022 Nov 01, 2022	BUY	$134.21 - $153.93 $240,370 - $275,688	1,791 Added 0.8%	224,362 $30.1 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $1.84 Million - $2.34 Million	-13,385 Reduced 5.67%	222,571 $34.1 Million
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $787,392 - $976,932	-5,966 Reduced 2.47%	235,956 $38.3 Million
Q4 2021 Jan 21, 2022	SELL	$107.43 - $135.93 $1.68 Million - $2.13 Million	-15,640 Reduced 6.07%	241,922 $32.8 Million
Q3 2021 Nov 01, 2021	BUY	$106.4 - $120.78 $27.4 Million - $31.1 Million	257,562 New	257,562 $27.8 Million

Others Institutions Holding ABBV

# of Institutions

3,850

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $311B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of U.S. Capital Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on U.S. Capital Wealth Advisors, LLC with notifications on news.

Account

U.S. Capital Wealth Advisors, LLC Abb Vie Inc. Transaction History